liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
All-cause mortality among breast cancer patients in a screening trial: Support for breast cancer mortality as an end point
Dept. of Math., Stat./Epidemiol., Cancer Research UK, London, United Kingdom.
Dept. of Math., Stat./Epidemiol., Cancer Research UK, London, United Kingdom.
Dept. of Math., Stat./Epidemiol., Cancer Research UK, London, United Kingdom.
Show others and affiliations
2002 (English)In: Journal of Medical Screening, ISSN 0969-1413, E-ISSN 1475-5793, Vol. 9, no 4, 159-162 p.Article in journal (Refereed) Published
Abstract [en]

Background: It has recently been suggested that all-cause mortality is a more appropriate end point than disease specific mortality in cancer screening trials, and that disease specific mortality is biased in favour of screening. This suggestion is based partly on supposed inconsistencies between all-cause mortality results and disease specific results in cancer screening trials, and alleged increases in deaths from causes other than breast cancer among breast cancer cases diagnosed among women invited to screening. Methods: We used data from the Swedish Two-County Trial of mammographic screening for breast cancer, in which 77 080 women were randomised to an invitation to screening and 55 985 to no invitation. We estimated relative risks (RRs) (invited v control) of death from breast cancer, death from other causes within the breast cancer cases, and death from all causes within the breast cancer cases. RRs were adjusted for age and took account of the longer follow up of breast cancer cases in the invited group due to lead time. Results: There was a significant 31% reduction in breast cancer mortality in the invited group (RR 0.69, 95% confidence interval (Cl) 0.58-0.80, p

Place, publisher, year, edition, pages
2002. Vol. 9, no 4, 159-162 p.
National Category
Natural Sciences
Identifiers
URN: urn:nbn:se:liu:diva-46842DOI: 10.1136/jms.9.4.159OAI: oai:DiVA.org:liu-46842DiVA: diva2:267738
Available from: 2009-10-11 Created: 2009-10-11 Last updated: 2017-12-13

Open Access in DiVA

No full text

Other links

Publisher's full text
By organisation
Department of Radiology UHL
In the same journal
Journal of Medical Screening
Natural Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 22 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf